Myelogenous-leukemia

Myelogenous-leukemia is a type of cancer that affects the bone marrow, where blood cells are made. It is characterized by an uncontrolled growth of abnormal white blood cells, called myeloid cells, in the bone marrow and other parts of the body. This can cause a variety of symptoms, such as fatigue, weight loss, anemia, and frequent infections. Myelogenous-leukemia can be fatal if left untreated, but treatment options such as chemotherapy, radiation therapy, stem cell transplantation, and targeted drug therapy can help to improve patient outcomes and lead to successful remission in some cases. Early detection and proper management of the disease are key to improving the prognosis of myelogenous-leukemia.

← Journal of Advances in Leukemia

Related Articles

1 journal(s) found

Advances in Leukemia

ISSN: Coming Soon
Type: Open Access Journal
Editor-in-Chief: Anil Tombak, Mersin University, Medical Faculty.
Journal of Advances in Leukemia is an advanced, peer reviewed journal which brings current information to all health care scientists involved in basic clinical research area. The Journal seeks high-quality submissions and welcome authors to submit articles of type reviews, letters, editorials, case reports, short communications and original researc